Kevin Caliendo
Stock Analyst at UBS
(4.17)
# 489
Out of 5,072 analysts
202
Total ratings
67.96%
Success rate
7.87%
Average return
Main Sectors:
Stocks Rated by Kevin Caliendo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SOLV Solventum | Maintains: Neutral | $77 → $79 | $85.27 | -7.35% | 2 | Nov 10, 2025 | |
| LFST LifeStance Health Group | Maintains: Buy | $9 → $10 | $6.56 | +52.44% | 6 | Nov 7, 2025 | |
| COR Cencora | Maintains: Buy | $380 → $415 | $368.53 | +12.61% | 4 | Nov 7, 2025 | |
| GDRX GoodRx Holdings | Maintains: Neutral | $4.25 → $4 | $2.83 | +41.34% | 7 | Nov 6, 2025 | |
| MCK McKesson | Maintains: Buy | $920 → $980 | $883.71 | +10.90% | 17 | Nov 6, 2025 | |
| OMI Owens & Minor | Downgrades: Neutral | $7 → $4 | $2.75 | +45.45% | 7 | Nov 3, 2025 | |
| CAH Cardinal Health | Maintains: Buy | $185 → $220 | $213.14 | +3.22% | 18 | Oct 31, 2025 | |
| ALHC Alignment Healthcare | Maintains: Neutral | $17 → $18 | $19.22 | -6.35% | 8 | Oct 31, 2025 | |
| UNH UnitedHealth Group | Maintains: Buy | $378 → $430 | $329.71 | +30.42% | 13 | Oct 29, 2025 | |
| LH Labcorp Holdings | Maintains: Buy | $325 → $320 | $268.27 | +19.28% | 7 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $23 | $11.29 | +103.72% | 12 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $170 | $148.33 | +14.61% | 5 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $79 → $96 | $79.86 | +20.21% | 10 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $190 | $189.69 | +0.16% | 16 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $160 → $155 | $147.23 | +5.28% | 19 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $75 → $70 | $75.26 | -6.99% | 6 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $18 → $22 | $20.99 | +4.81% | 4 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $15 | $4.20 | +257.14% | 3 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $9 | $4.11 | +118.98% | 3 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $410 → $390 | $278.35 | +40.11% | 11 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $380 → $250 | $245.99 | +1.63% | 6 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $72 → $79 | $39.46 | +100.20% | 2 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $610 → $575 | $338.52 | +69.86% | 1 | Jul 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $185 → $180 | $207.56 | -13.28% | 7 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $130 → $72 | $7.45 | +866.44% | 4 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $15 → $11 | $26.32 | -58.21% | 4 | May 4, 2021 |
Solventum
Nov 10, 2025
Maintains: Neutral
Price Target: $77 → $79
Current: $85.27
Upside: -7.35%
LifeStance Health Group
Nov 7, 2025
Maintains: Buy
Price Target: $9 → $10
Current: $6.56
Upside: +52.44%
Cencora
Nov 7, 2025
Maintains: Buy
Price Target: $380 → $415
Current: $368.53
Upside: +12.61%
GoodRx Holdings
Nov 6, 2025
Maintains: Neutral
Price Target: $4.25 → $4
Current: $2.83
Upside: +41.34%
McKesson
Nov 6, 2025
Maintains: Buy
Price Target: $920 → $980
Current: $883.71
Upside: +10.90%
Owens & Minor
Nov 3, 2025
Downgrades: Neutral
Price Target: $7 → $4
Current: $2.75
Upside: +45.45%
Cardinal Health
Oct 31, 2025
Maintains: Buy
Price Target: $185 → $220
Current: $213.14
Upside: +3.22%
Alignment Healthcare
Oct 31, 2025
Maintains: Neutral
Price Target: $17 → $18
Current: $19.22
Upside: -6.35%
UnitedHealth Group
Oct 29, 2025
Maintains: Buy
Price Target: $378 → $430
Current: $329.71
Upside: +30.42%
Labcorp Holdings
Oct 29, 2025
Maintains: Buy
Price Target: $325 → $320
Current: $268.27
Upside: +19.28%
Oct 28, 2025
Maintains: Buy
Price Target: $24 → $23
Current: $11.29
Upside: +103.72%
Oct 24, 2025
Maintains: Neutral
Price Target: $180 → $170
Current: $148.33
Upside: +14.61%
Oct 24, 2025
Maintains: Buy
Price Target: $79 → $96
Current: $79.86
Upside: +20.21%
Oct 17, 2025
Maintains: Neutral
Price Target: $180 → $190
Current: $189.69
Upside: +0.16%
Oct 16, 2025
Maintains: Neutral
Price Target: $160 → $155
Current: $147.23
Upside: +5.28%
Aug 6, 2025
Maintains: Neutral
Price Target: $75 → $70
Current: $75.26
Upside: -6.99%
Jul 29, 2025
Maintains: Neutral
Price Target: $18 → $22
Current: $20.99
Upside: +4.81%
May 9, 2025
Maintains: Buy
Price Target: $14 → $15
Current: $4.20
Upside: +257.14%
May 8, 2025
Maintains: Neutral
Price Target: $12 → $9
Current: $4.11
Upside: +118.98%
Feb 3, 2025
Maintains: Buy
Price Target: $410 → $390
Current: $278.35
Upside: +40.11%
Oct 4, 2024
Maintains: Neutral
Price Target: $380 → $250
Current: $245.99
Upside: +1.63%
Dec 21, 2023
Maintains: Neutral
Price Target: $72 → $79
Current: $39.46
Upside: +100.20%
Jul 13, 2023
Maintains: Buy
Price Target: $610 → $575
Current: $338.52
Upside: +69.86%
Jul 21, 2022
Maintains: Neutral
Price Target: $185 → $180
Current: $207.56
Upside: -13.28%
Mar 8, 2022
Maintains: Neutral
Price Target: $130 → $72
Current: $7.45
Upside: +866.44%
May 4, 2021
Downgrades: Neutral
Price Target: $15 → $11
Current: $26.32
Upside: -58.21%